PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+42.22%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$3.47B
AUM Growth
+$3.47B
(+0.85%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-4.17%
Top 10 Holdings %
Top 10 Hldgs %
46.93%
Holding
128
New
11
Increased
19
Reduced
26
Closed
30
Top Buys
| 1 |
Madrigal Pharmaceuticals
MDGL
|
$116M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$109M |
| 3 |
Vaxcyte
PCVX
|
$56.1M |
| 4 |
Sarepta Therapeutics
SRPT
|
$51.3M |
| 5 |
Acrivon Therapeutics
ACRV
|
$34.7M |
Top Sells
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$158M |
| 2 |
Relmada Therapeutics
RLMD
|
$88.2M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$43.3M |
| 4 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$28.1M |
| 5 |
Edwards Lifesciences
EW
|
$27.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALBO
26
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $38M | 1.07% |
1,757,160
-602,979
| -26% | -$13M |
|
27
Cogent Biosciences
COGT
$1.83B
| $37.1M | 1.04% |
3,207,441
| – | – |
|
28
Viridian Therapeutics
VRDN
$1.59B
| $35.7M | 1% |
1,220,575
| – | – |
|
29
RAPT Therapeutics
RAPT
$187M
| $35.6M | 1% |
224,869
+10,727
| +5% | +$1.7M |
|
30
Zymeworks
ZYME
$1.07B
| $35.5M | 1% |
4,511,275
+111,176
| +3% | +$874K |
|
|
31
Acrivon Therapeutics
ACRV
$42.2M
| $34.7M | 0.97% |
+3,007,858
| New | +$34.7M |
|
32
Establishment Labs
ESTA
$1.11B
| $32.7M | 0.92% |
497,857
-80,396
| -14% | -$5.28M |
|
33
Astria Therapeutics
ATXS
$372M
| $32.6M | 0.92% |
2,189,462
+908,265
| +71% | +$13.5M |
|
|
CINC
34
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $31.7M | 0.89% |
2,576,325
-730,324
| -22% | -$8.98M |
|
35
Immatics
IMTX
$662M
| $30.4M | 0.85% |
3,491,500
+991,500
| +40% | +$8.64M |
|
36
Relay Therapeutics
RLAY
$709M
| $29M | 0.82% |
1,943,097
| – | – |
|
37
Lyra Therapeutics
LYRA
$11.8M
| $28.7M | 0.81% |
182,935
| – | – |
|
38
Outset Medical
OM
$245M
| $28.1M | 0.79% |
72,628
-5,281
| -7% | -$2.05M |
|
39
Harmony Biosciences
HRMY
$2.16B
| $22.7M | 0.64% |
411,804
| – | – |
|
40
Rocket Pharmaceuticals
RCKT
$358M
| $21.1M | 0.59% |
1,078,204
+578,204
| +116% | +$11.3M |
|
|
VBIV
41
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $20.4M | 0.57% |
1,744,500
| – | – |
|
|
RAIN
42
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $19.9M | 0.56% |
2,483,619
| – | – |
|
43
Akero Therapeutics
AKRO
$3.65B
| $19.2M | 0.54% |
350,525
-79,475
| -18% | -$4.36M |
|
44
Tarsus Pharmaceuticals
TARS
$2.44B
| $19M | 0.53% |
1,296,416
| – | – |
|
45
Solid Biosciences
SLDB
$448M
| $18.8M | 0.53% |
3,495,933
+2,601,763
| +291% | +$14M |
|
46
Nautilus Biotechnolgy
NAUT
$80.7M
| $16.4M | 0.46% |
9,111,151
| – | – |
|
47
Roivant Sciences
ROIV
$8.6B
| $15.8M | 0.44% |
+1,981,570
| New | +$15.8M |
|
48
Athira Pharma
ATHA
$15.5M
| $15.2M | 0.43% |
4,797,278
| – | – |
|
49
Prothena Corp
PRTA
$452M
| $14.3M | 0.4% |
237,646
+7,646
| +3% | +$461K |
|
50
Verrica Pharmaceuticals
VRCA
$49.4M
| $13.9M | 0.39% |
503,898
| – | – |
|